Background: Isatuximab is a CD38 monoclonal antibody approved for use in combination with pomalidomide plus dexamethasone to treat adults with relapsed/refractory multiple myeloma who have received at least two prior therapies. Because isatuximab is a relatively new treatment option, published...

I decided to pursue a career in nursing because I believe it is a career that plays to my strengths of being a compassionate and empathetic individual with an internal drive to care for others. Throughout my life, I have had a handful of close family and friends be diagnosed with cancer, and these...

Purpose: To explore the ways in which multiple myeloma affects an individual’s life in the modern treatment era. Participants & Setting: 15 individuals with multiple myeloma and 10 clinicians were recruited from two academic medical centers in the southeastern United States. Methodologic...

Background: Despite known disparities by race, studies to date have not focused on pain characterization among African American patients with multiple myeloma. Objectives: This study aimed to characterize the pain experience, beliefs about pain and pain control, and additional symptoms among...